PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 19.11.2019 at 4:00 PM CET
Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (CA2748392) USE OF INTERLEUKIN-22 FOR THE PREVENTION AND/OR TREATMENT OF MULTIPLE ORGAN DYSFUNCTION SYNDROME (MODS)

Office : Canada
Application Number: 2748392 Application Date: 11.01.2010
Publication Number: 2748392 Publication Date: 15.07.2010
Grant Number: Grant Date: 27.06.2017
Publication Kind : C
Prior PCT appl.: Application Number:PCTUS2010020673 ; Publication Number: Click to see the data
IPC:
A61K 38/20
C07K 14/54
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
19
Cytokines; Lymphokines; Interferons
20
Interleukins
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435
from animals; from humans
52
Cytokines; Lymphokines; Interferons
54
Interleukins (IL)
CPC:
A61K 38/20
A61K 38/2066
Applicants: GENERON (SHANGHAI) CORPORATION
Inventors:
Priority Data: 61/144,134 12.01.2009 US
Title: (EN) USE OF INTERLEUKIN-22 FOR THE PREVENTION AND/OR TREATMENT OF MULTIPLE ORGAN DYSFUNCTION SYNDROME (MODS)
(FR) PREVENTION ET/OU TRAITEMENT DU SYNDROME DE DEFAILLANCE MULTIVISCERALE AVEC DE L'INTERLEUKINE 22
Abstract: front page image
(EN)

The present invention relates to use an agent for the prevention and/or
treatment of multiple organ dysfunction
syndrome (MODS) or multiple organ failure (MOF) comprising interleukin-22 (IL-
22) as an effective ingredient. The present invention
is applicable to prevention of or therapy for diseases from sepsis, septic
shock, liver failure, to multiple organ dysfunction
syndromes. More particularly, the present invention is useful for an emergency
medical service, for treatment of injury caused by a
traffic accident, burns, heat attacks, hypercytokinemia or severe infective
diseases.


Also published as:
EP2385841JP2012515165US20110268696CN102348463AU2010203446WO/2010/081112